×

Open WeChat and scan the QR code
Subscribe to our WeChat public account

HOME Overview Professional Fields Industry Fields Professionals Global Network News Publications Join Us Contact Us Subscribe CN EN JP
HOME > Publications > Newsletter > taptap点点官方网站 Introduces Measures to Support High-Caliber Foreign-Invested Biomedical Projects

taptap点点官方网站 Introduces Measures to Support High-Caliber Foreign-Invested Biomedical Projects

 2026-08-31604

ISSUING AUTHORITIES:

taptap点点官方网站 Municipal Science and Technology Commission

taptap点点官方网站 Municipal Development and Reform Commission

taptap点点官方网站 Municipal Commission of Commerce

taptap点点官方网站 Municipal Health Commission

taptap点点官方网站 Medical Products Administration

DATE OF ISSUANCE:

June 3, 2026

EFFECTIVE DATE:

June 3, 2026

 

taptap点点官方网站 has issued the taptap点点官方网站 Support the Implementation of High-Caliber Projects by Foreign-Invested Biomedical Enterprises(the“Measures”), jointly released by five municipal authorities. Effective June 3, the Measures set out 25 concrete provisions across project rollout, R&D, manufacturing, clinical trials, regulatory review, and taptap点点官方网站, with a validity period through June 21, 2029.

 

The Measures support foreign-invested biomedical enterprises in establishing manufacturing bases, R&D centers, global or regional headquarters and other functional platforms in taptap点点官方网站. Major projects with advanced technologies and strong industrial impact may be included in municipal level major foreign-invested project lists and receive coordinated services covering market access, planning, environmental protection, construction, foreign exchange and import and export procedures.

 

The Measures also introduce support for R&D and commercialization activities, including the establishment of global R&D centers and innovation platforms, cooperation with local research institutions and medical institutions, international multi-center clinical trials, and the localization of imported drugs and medical devices. Relevant regulatory services, including optimized review and inspection procedures, are provided to facilitate product registration and taptap点点官方网站.

 

In addition, the Measures address operational issues of taptap点点官方网站 biomedical enterprises, including cross-border data transfers, customs clearance for R&D material, intellectual property protection and investment expansion. A dedicated service mechanism will be established for high-caliber projects, with projects involving a total investment of RMB 1 billion or more eligible for inclusion in the service mechanism for multinational corporations.

 

The Measures give foreign investors clearer, faster pathways to move R&D, manufacturing, and regional headquarters into taptap点点官方网站.

 

Reference:


沪ICP备05002643号